comparemela.com

Latest Breaking News On - Clinical global impressions severity - Page 1 : comparemela.com

Post Hoc Analysis Explores Risk-Benefit Profile of KarXT

Post Hoc Analysis Explores Risk-Benefit Profile of KarXT
psychiatrictimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychiatrictimes.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Nichole-neugebauer
Drug-administration
American-society-of-clinical-psychopharmacology
American-society-of-clinical-psychopharmacology-annual-meeting
Clinical-psychopharmacology
Annual-meeting
Negative-syndrome-scale
Clinical-global-impressions-severity
Psychiatric-times
Clinical-psychopharmacology-annual

Investigators Share Baseline Data From Study on Iclepertin for Schizophrenia at APA Annual Meeting

Investigators Share Baseline Data From Study on Iclepertin for Schizophrenia at APA Annual Meeting
psychiatrictimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychiatrictimes.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Satoru-ikezawa
Zuzana-blahova
Corey-reuteman-fowler
Stephenr-marder
Connex
American-psychiatric-association
World-health-organization
Psychiatric-association
Annual-meeting
Clinical-global-impressions-severity

Single Dose of LSD-Containing Drug Improved Anxiety Symptoms

The psychedelic was administered without psychotherapy pairing

United-states
New-york
American
American-psychiatric-association
Pamerican-psychiatric-association
Hamilton-anxiety-rating-scale
Psychiatric-association
Clinical-global-impressions-severity
Montgomery-asberg-depression-rating-scale
New-york-city

Olanzapine/Samidorphan Maintains Mood Disorder Efficacy, Weight and Glycemic Tolerability at 4 Years

Four-year, phase 3 data from APA 2024 show olanzapine/samidorphan provided consistent antipsychotic efficacy and weight-related safety in patients with either schizophrenia or bipolar I disorder.

United-states
New-york
American
Renes-kahn
Icahn-school-of-medicine-mount-sinai
American-psychiatric-association
Icahn-school
Mount-sinai
Clinical-global-impressions-severity
Apa
Aapa-2024

FDA Approves Iloperidone for Adults with Bipolar 1 Disorder

Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder.

Stephen-stahl
Mihaelh-polymeropoulos
Iloperidone-fanapt
Vanda-pharmaceuticals-inc
University-of-california-san-diego
Vanda-pharmaceuticals
California-san-diego
Image-credit
Young-mania-rating-scale
Clinical-global-impressions-severity
Clinical-global-impression
Pharmaceutical-fanapt

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.